Zoeken
More News Articles
All News
21 augustus 2023
The core protocol for phase 2/3 clinical trial(s) in VWM is now published
The core protocol for phase 2/3 clinical trial(s) in VWM, aimed to serve as a template for industry-sponsored clinical trials in VWM, is now published.
26 april 2023
Calico Life Sciences Announces First Participant Dosed in Phase 1b Clinical Study Evaluating ABBV-CLS-7262 for the Treatment of Vanishing White Matter Disease
Calico Life Sciences Announces First Participant Dosed in Phase 1b Clinical Study Evaluating ABBV-CLS-7262 for the Treatment of Vanishing White Matter Disease
26 maart 2023
Calico starts phase 1b study evaluating safety, tolerability and pharmacokinetics of eIF2B activator
Calico starts phase 1b study evaluating safety, tolerability and pharmacokinetics of eIF2B activator.